Steps to reduce import dependence: PLI schemes for pharma/medical devices, urea self-sufficiency measures, and NBS policy actions for P&K fertilizers
Government measures on pharmaceuticals, medical devices, urea, and phosphatic-potassic fertilizers to cut import dependence
- The Department of Pharmaceuticals is implementing three Production Linked Incentive schemes to expand domestic manufacturing in pharmaceuticals and medical devices.
- The Department of Fertilizers is using the Nutrient Based Subsidy Scheme, Open General Licence treatment, and price guidelines to manage phosphatic and potassic fertilizer availability.
- The New Investment Policy and the New Urea Policy are being used together to expand domestic urea capacity and improve efficiency in existing gas-based units.
What happened
The Government of India has outlined measures to reduce import dependence in pharmaceuticals, medical devices, urea, and phosphatic-potassic fertilizers. The measures combine industrial incentives, capacity expansion, and subsidy design to support atmanirbharta in two strategically important input sectors.
Pharmaceuticals and medical devices
Relevant for GS3: Indian economy: industrial policy, import substitution, and manufacturing, GS3: Agriculture: fertilizer subsidy, nutrient management, and input availability, GS3: Science and Technology: pharmaceuticals and medical devices ecosystem. The Government of India has reported progress under Production Linked Incentive schemes for pharmaceuticals and medical devices, along with measures to raise domestic urea output and support phosphatic and potassic fertilizers under the Nutrient Based Subsidy regime. The note is relevant because it links industrial policy, fertilizer subsidy design, and import substitution in two core economy sectors.
Related dispatches
